000 01373nam a2200385 i 4500
001 ocn960809876
003 OCoLC
005 20170208053812.0
006 m o d f
007 cr mn|||||||||
008 161017s1998 dcua ob f000 0 eng c
040 _aGPO
_beng
_erda
_epn
_cGPO
042 _apcc
043 _an-us---
074 _a0445-B-07 (online)
086 0 _aHE 1.75:OEI-05-97-00241
088 _aOEI-05-97-00241
099 _aHE 1.75:OEI-05-97-00241
110 1 _aUnited States.
_bDepartment of Health and Human Services.
_bOffice of Inspector General,
_eauthor.
245 1 0 _aIndependent physiological laboratories :
_bcarrier perspectives.
264 1 _a[Washington, D.C.] :
_bDepartment of Health and Human Services, Office of Inspector General,
_c1998.
300 _a1 online resource (2, 7 pages)
337 _2rdamedia
338 _2rdacarrier
500 _aTitle from title screen (viewed Oct. 14, 2016).
500 _a"August 1998."
500 _a"OEI-05-97-00241."
500 _aCRDP Project record.
504 _aIncludes bibliographical references (page 7).
650 0 _aMedicare fraud.
650 0 _aPhysiological laboratories
_zUnited States.
650 0 _aMedical laboratories
_xAccreditation
_zUnited States.
856 4 0 _uhttp://purl.fdlp.gov/GPO/gpo73452
949 _aBEV
_bFed Docs
999 _c257040
_d257040